Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Ductal Adenocarcinoma (PDAC)

Explore clinical trials studying Pancreatic Ductal Adenocarcinoma (PDAC). Study availability and eligibility vary by location and protocol.

76 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Ductal Adenocarcinoma (PDAC) trial results

Recruiting

SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors

NCT07812805

Conditions
Biliary Tract Cancer (BTC), Biliary Tract Diseases, Biliary Tract Neoplasms, +22 more
Locations
  • United Theranostics Glen Burnie, Maryland, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
  • Seoul National University Hospital Seoul, South Korea
  • Asan Medical Center Seoul, South Korea
View Trial Details
Recruiting

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

NCT07644559

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • START- Los Angeles Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 29 locations
View Trial Details
Recruiting

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

NCT07227168

Conditions
Cervical Cancer, Colonic Diseases, Colorectal Cancer, +34 more
Locations
  • SCRI Denver Denver, Colorado, United States
  • SCRI FCS Sarasota Sarasota, Florida, United States
  • Mass General Cancer Center Boston, Massachusetts, United States
  • NEXT Austin Austin, Texas, United States
View Trial Details
Recruiting

A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

NCT05706129

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +38 more
Locations
  • Peter MacCallum Cancer Centre Melbourne, Australia
  • UNSW Sydney, St Vincent's Hospital Sydney Sydney, Australia
  • Centre Jean Perrin Clermont-Ferrand, France
  • Centre Georges François Leclerc Dijon, France
View Trial Details
Recruiting

A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer

NCT07255404

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Tsinghua Changgung Hospital Beijing, China
  • Sichuan Cancer Hospital Chengdu, China
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, China
  • Zhejiang Provincial People's Hospital Hangzhou, China
View all 24 locations
View Trial Details
Recruiting

Panuri Performance Study

NCT07587866

Conditions
Pancreatic Ductal Adenocarcinoma (PDAC)
Locations
  • Békés Megyei Központi Kórház Dr. Réthy Pál Tagkórház Békéscsaba, Hungary
  • Pankreász Betegségek Intézete Semmelweis Egyetem Budapest, Hungary
  • Bács-Kiskun Vármegyei Oktatókórház Kecskemét, Hungary
  • Csőszi Endoszkópos Kft. Kecskemét, Hungary
View all 32 locations
View Trial Details

Related conditions